Human immunodeficiency virus-associated prostate cancer: Clinicopathological findings and outcome in a multi-institutional study

BJU International

Volumn 101, Issue 12, 2008, Pages 1519-1523

  Pantanowitz, Liron ^a,f   Bohac, Gerry ^d   Cooley, Timothy P ^b   Aboulafia, David ^e   Dezube, Bruce J ^c  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d RUSH MEDICAL COLLEGE   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f BAYSTATE MEDICAL CENTER   (United States)

Author keywords

AIDS; Cancer; HAART; HIV; Prostate

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTINEOPLASTIC AGENT; CD4 ANTIGEN; PROSTATE SPECIFIC ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER HORMONE THERAPY; CANCER SCREENING; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; ITALY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; RETROSPECTIVE STUDY; SWITZERLAND; TREATMENT OUTCOME; UNITED KINGDOM; UNITED STATES; UNSPECIFIED SIDE EFFECT; VIREMIA; VIRUS CARCINOGENESIS; VIRUS DIAGNOSIS; VIRUS LOAD;

AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; VIRAL LOAD;

EID: 43949094532     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.07474.x     Document Type: Article

References (40)

1. Pantanowitz L, Schlecht HP, Dezube BJ. The growing problem of non-AIDS defining malignancies in HIV. Curr Opin Oncol 2006 18 : 469 78
2. Walters Z, Shamash J, Powles T. Prostate cancer in HIV-positive individuals: what we know and what we don't. J HIV Ther 2007 12 : 66 7
3. Crum NF, Hale B, Utz G, Wallace M. Increased risk of prostate cancer in HIV infection? AIDS 2002 16 : 1703 4
4. Quatan N, Nair S, Harrowes F, Hay P. Should HIV patients be considered a high risk group for the development of prostate cancer? Ann R Coll Surg Engl 2005 87 : 437 8
5. Smith DM, Kingery JD, Wong JK, Ignacio CC, Richman DD, Little SJ. The prostate as a reservoir for HIV-1. AIDS 2004 18 : 1600 2
6. Montgomery JD, Jacobson LP, Dhir R, Jenkins FJ. Detection of human herpesvirus 8 (HHV-8) in normal prostates. Prostate 2006 66 : 1302 10
7. Jenkins FJ, Hayes RB, Jackson A et al. Human herpesvirus 8 seroprevalence among prostate cancer case patients and control subjects. J Infect Dis 2007 196 : 208 11
8. Leport C, Rousseau F, Perronne C, Salmon D, Joerg A, Vilde JL. Bacterial prostatitis in patients infected with the human immunodeficiency virus. J Urol 1989 141 : 334 6
9. Santillo VM, Lowe FC. The management of chronic prostatitis in men with HIV. Curr Urol Rep 2006 7 : 313 9
10. Palapattu GS, Sutcliffe S, Bastian PJ et al. Prostate carcinogenesis and inflammation: emerging insights. Carcinogenesis 2005 26 : 1170 81
11. Leibovitz A, Baumoehl Y, Segal R. Increased incidence of pathological and clinical prostate cancer with age: age related alterations of local immune surveillance. J Urol 2004 172 : 435 7
12. Konety BR, Tewari A, Howard RJ et al. Prostate cancer in the post-transplant population. Urologic Society for Transplantation and Vascular Surgery. Urology 1998 52 : 428 32
13. Crum NF, Spencer CR, Amling CL. Prostate carcinoma among men with human immunodeficiency virus infection. Cancer 2004 101 : 294 9
14. Biggar RJ, Kirby KA, Atkinson J, McNeel TS, Engels E, the AIDS Cancer Match Study Group. Cancer risk in elderly persons with HIV/AIDS. J Acquir Immune Defic Syndr 2004 36 : 861 8
15. Burgi A, Brodine S, Wegner S et al. Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals. Cancer 2005 104 : 1505 11
16. Hessol NA, Pipkin S, Schwarcz S, Cress RD, Bacchetti P, Scheer S. The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS. Am J Epidemiol 2007 165 : 1143 53
17. Frisch M, Biggar RJ, Engels EA, Goedert JJ, AIDS-Cancer Match Registry Study Group. Association of cancer with AIDS-related immunosuppression in adults. JAMA 2001 285 : 1736 45
18. Dal Maso L, Franceschi S, Polesel J et al. Risk of cancer in persons with AIDS in Italy, 1985-1998. Br J Cancer 2003 89 : 94 100
19. Clifford GM, Polesel J, Rickenbach M, et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 2005 97 : 425 32
20. Grulich AE, Li Y, McDonald A, Correll PK, Law MG, Kaldor JM. Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis. AIDS 2002 16 : 1155 61
21. Newnham A, Harris J, Evans HS, Evans BG, Møller H. The risk of cancer in HIV-infected people in southeast England: a cohort study. Br J Cancer 2005 92 : 194 200
22. Engels EA, Pfeiffer RM, Goedert JJ et al. Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS 2006 20 : 1645 54
23. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 2007 370 : 59 67
24. Santos J, Palacios R, Ruiz J, Gonzalez M, Marquez M. Unusual malignant tumours in patients with HIV infection. Int J STD AIDS 2002 13 : 674 6
25. Kwan DJ, Lowe FC. Genitourinary manifestations of the acquired immunodeficiency syndrome. Urology 1995 45 : 13 27
26. Manfredi R, Fulgaro C, Sabbatani S, Dentale N, Legnani G. Disseminated, lethal prostate cancer during human immunodeficiency virus infection presenting with non-specific features. Open questions for urologists, oncologists, and infectious disease specialists. Cancer Detect Prev 2006 30 : 20 3
27. Levinson A, Nagler EA, Lowe FC. Approach to management of clinically localized prostate cancer in patients with human immunodeficiency virus. Urology 2005 65 : 91 4
28. Schwartz JD, Prince D. Prostate cancer in HIV infection. AIDS 1996 10 : 797 8
29. Furco A, Bani-Sadr F, Guymar S, Molina JM. [Metastatic cancer of the prostate in a young 40 year-old HIV-infected male patient]. Presse Med 2003 32 : 930 1
30. Huang WC, Kwon EO, Scardino PT, Eastham JA. Radical prostatectomy in patients infected with human immunodeficiency virus. BJU Int 2006 98 : 303 7
31. Sugar LM. Inflammation and prostate cancer. Can J Urol 2006 13 (Suppl. 1 46 7
32. De Marzo AM, Platz EA, Sutcliffe S et al. Inflammation in prostate carcinogenesis. Nat Rev Cancer 2007 7 : 256 69
33. Vianna LE, Lo Y, Klein RS. Serum prostate-specific antigen levels in older men with or at risk of HIV infection. HIV Med 2006 7 : 471 6
34. Green FL, Page DL, Fleming ID et al. eds. American Joint Committee on Cancer Cancer Staging Manual, 6th edn. New York : Springer, 2002 : 309 13
35. Roach PJ, Fleming C, Hagen MD, Pauker SG. Prostatic cancer in a patient with asymptomatic HIV infection: are some lives more equal than others? Med Decis Making 1988 8 : 132 44
36. Staiman V, Lowe FC. Prostatic disease in HIV infected patients. Infect Urol 1996 9 : 42 7
37. O'Connor JK, Nedzi LA, Zakris EL. Prostate adenocarcinoma and human immunodeficiency virus: report of three cases and review of the literature. Clin Genitourin Cancer 2006 5 : 85 8
38. Silverberg MJ, Neuhaus J, Bower M et al. Risk of cancers during interrupted antiretroviral therapy in the SMART study. AIDS 2007 21 : 1957 63
39. Ikezoe T, Hisatake Y, Takeuchi T et al. HIV-1 protease inhibitor, ritonavir: a potent inhibitor of CYP3A4, enhanced the anticancer effects of docetaxel in androgen-independent prostate cancer cells in vitro and in vivo. Cancer Res 2004 64 : 7426 31
40. Biggar RJ, Engels EA, Ly S et al. Survival after cancer diagnosis in persons with AIDS. J Acquir Immune Defic Syndr 2005 39 : 293 9